Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer
Authors:
- 3 August 2020
- journal article
- research article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 28 (4) , 439-446
Abstract
BACKGROUND: Non-small cell lung cancer (NSCLC) is the major subtype of lung cancer, imposing a huge disease burden worldwide. MicroRNA-1303 (miR-1303) has been demonstrated to be involved in several diseases, including cancers. In this study, we aimeKeywords
This publication has 30 references indexed in Scilit:
- Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancerCancer Gene Therapy, 2016
- Lung Cancer Statistics2015
- Epidemiology of Lung Cancer2015
- Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinibLung Cancer, 2015
- miR-1303 Targets Claudin-18 Gene to Modulate Proliferation and Invasion of Gastric Cancer CellsDigestive Diseases and Sciences, 2014
- miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressivenessInternational Journal of Cancer, 2013
- Risk factors for primary lung cancer among never smokers by gender in a matched case–control studyCancer Causes & Control, 2012
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004